Licensing Executive Society (LES) 2008 Annual Meeting

October 20, 2008. Prism Pharmaceuticals CEO, Dr. Warren Cooper, will be a panelist at the LES Annual Meeting to be held Monday, October 20, at the Gaylord Palms Conference Center, Kissimmee, Florida. The workshop session is entitled, Strategic BioPharma Deal making: Has Alternative Financing Come of Age? 

PA Bio CEO Roundtable

September 25, 2008. Prism Pharmaceuticals CEO, Dr. Warren Cooper, will participate as one of three panelists at the Pennsylvania Bio CEO Roundtable with Dr. Frank Baldino, CEO, Cephalon Inc. and Paul Touhey, CEO, Fujirebio Diagnostics, Inc.

NEXTERONE NDA Filing by FDA

April 25, 2008. The Food and Drug administration today informed Prism Pharmaceuticals that it filed the new drug application (NDA) for NEXTERONE® (amiodarone HCl) Injection for standard review leading to a PDUFA date of December 25, 2008.